Global Contract Research Organization (CRO) Market

reogma|Global Contract Research Organization (CRO) Market

The Global Contract Research Organization (CRO) Market is poised to grow at a CAGR of 7.4% to reach a Market Size of USD 63,160 million by 2026 from a value of USD 44,214 million in 2021. The Market is driven by factors such as Increasing investment in pharmaceutical R&D to drive the CROs services market, Government aids and Adoption of CROs Services to Accelerate Early Phase Drug Development.

  • Definition / Scope
  • Market Overview
  • Market Risks
  • Market Drivers
  • Market Restraints
  • Industry Challenges
  • Technology Trends
  • Regulatory Trends
  • Post COVID-19 Recovery
  • Market Size and Forecast
  • Market Outlook
  • Technology Roadmap
  • Competitive Landscape
  • Competitive Factors
  • Key Market Players
  • Strategic Conclusion
  • References
  • Appendix

Definition / Scope

Contract Research Organizations (CROs) are organizations that facilitate the outsourcing of research and development services for a variety of industries, including biotechnology, pharmaceuticals, medical device industries, universities, government institutions, and foundations. Contract research organizations are experiencing a surge in demand, fueled by advancements in clinical development programme and the global demand for innovative pharmaceutical products.

Pharmaceutical product research and development can take up to 15 years. Pharmaceutical companies prefer to outsource preclinical and other drug development phases to CROs in order to save money on R&D and shorten the time it takes to market a product. Furthermore, a high failure rate of clinical trials is expected to fuel the demand for CROs by pharmaceutical and biopharmaceutical vendors looking to outsource their R&D.

The contract research organization market is divided into four sections: service type, therapeutic area, end user, and geography. Clinical research services (phase I clinical research services, phase II clinical research services, phase III clinical research services, and phase IV clinical research services), early-phase development services, laboratory services, and consulting services are the market's service types. Oncology, infectious diseases, central nervous system (CNS) disorders, immunological disorders, cardiovascular diseases, respiratory disorders, diabetes, and other therapeutic areas comprise the market. The market is divided into three end users: pharmaceutical and biopharmaceutical companies, medical device companies, and academic institutes. The market is divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.

reogma|Global Contract Research Organization (CRO) Market


This report is 19 mins read | Subscribe now to read further.

Access all reports on site for only US$9.99/mo


Leave a Reply

Next Post

Global Gear Pump Market

Fri Feb 18 , 2022
The Global Contract Research Organization (CRO) Market is poised to grow at a CAGR of 7.4% to reach a Market Size of USD 63,160 million by 2026 from a value of USD 44,214 million in 2021. The Market is driven by factors such as Increasing investment in pharmaceutical R&D to […]
reogma|Global Contract Research Organization (CRO) Marketreogma|Global Contract Research Organization (CRO) Market

Tags

Tags

Newsletter Signup

Subscribe to our newsletter below and never miss the latest product or an exclusive offer.